Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Combined Targeting Patient-Specific Anti-Apoptotic Molecules and CXCR4-Expressing CAR-T Cells Eliminated High-Inflammation State Leukemia with Poor-Prognostic Mutations

Blood (2024) 144 (Supplement 1): 1453.

https://doi.org/10.1182/blood-2024-204989

Published: 2024

Journal Articles

Germ line DDX41 mutations define a unique subtype of myeloid neoplasms

Hideki Makishima, Ryunosuke Saiki, Yasuhito Nannya, Sophia Korotev, Carmelo Gurnari, June Takeda, Yukihide Momozawa, Steve Best, Pramila Krishnamurthy, Tetsuichi Yoshizato, Yoshiko Atsuta, Yusuke Shiozawa, Yuka Iijima-Yamashita, Kenichi Yoshida, Yuichi Shiraishi, Yasunobu Nagata, Nobuyuki Kakiuchi, Makoto Onizuka, Kenichi Chiba, Hiroko Tanaka, Ayana Kon, Yotaro Ochi, Masahiro M. Nakagawa, Rurika Okuda, Takuto Mori, Akinori Yoda, Hidehiro Itonaga, Yasushi Miyazaki, Masashi Sanada, Takayuki Ishikawa, Shigeru Chiba, Hisashi Tsurumi, Senji Kasahara, Carsten Müller-Tidow, Akifumi Takaori-Kondo, Kazuma Ohyashiki, Toru Kiguchi, Fumihiko Matsuda, Joop H. Jansen, Chantana Polprasert, Piers Blombery, Yoichiro Kamatani, Satoru Miyano, Luca Malcovati, Torsten Haferlach, Michiaki Kubo, Mario Cazzola, Austin G. Kulasekararaj, Lucy A. Godley, Jaroslaw P. Maciejewski, Seishi Ogawa

Blood (2023) 141 (5): 534–549.

https://doi.org/10.1182/blood.2022018221

Published: 2023

Includes: Supplemental data

Journal Articles

Detailed Analysis of the Impact of Clonal Hematopoiesis on the Risk of Severe COVID-19 Infection

Blood (2022) 140 (Supplement 1): 5747–5748.

https://doi.org/10.1182/blood-2022-160436

Published: 2022

Journal Articles

Germline Risks and Clinical Impacts of DDX41 Mutations in Myeloid Malignancies

Hideki Makishima, Ryunosuke Saiki, Yasuhito Nannya, Sophia C. Korotev, Carmelo Gurnari, June Takeda, Yukihide Momozawa, Steve Best, Pramila Krishnamurthy, Tetsuichi Yoshizato, Yoshiko Atsuta, Yusuke Shiozawa, Yuka Iijima-Yamashita, Kenichi Yoshida, Yuichi Shiraishi, Yasunobu Nagata, Nobuyuki Kakiuchi, Makoto Onizuka, Kenichi Chiba, Hiroko Tanaka, Ayana Kon, Yotaro Ochi, Masahiro Marshall Nakagawa, Rurika Okuda, Takuto Mori, Akinori Yoda, Hidehiro Itonaga, Yasushi Miyazaki, Masashi Sanada, Takayuki Ishikawa, Shigeru Chiba, Hisashi Tsurumi, Senji Kasahara, Carsten Müller-Tidow, Akifumi Takaori-Kondo, Kazuma Ohyashiki, Toru Kiguchi, Fumihiko Matsuda, Joop H. Jansen, Chantana Polprasert, Piers Blombery, Yoichiro Kamatani, Satoru Miyano, Luca Malcovati, Torsten Haferlach, Michiaki Kubo, Mario Cazzola, Austin Kulasekararaj, Lucy A. Godley, Jaroslaw P. Maciejewski, Seishi Ogawa

Blood (2022) 140 (Supplement 1): 208–210.

https://doi.org/10.1182/blood-2022-158851

Published: 2022

Journal Articles

ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia

Blood (2022) 140 (3): 274–284.

https://doi.org/10.1182/blood.2021014240

Published: 2022

Includes: Supplemental data

Journal Articles

Identification of Patient-Specific Anti-Apoptotic Molecules As Therapeutic Targets in Poor Prognosis Acute Lymphoblastic Leukemia (ALL)

Ryo Nakagawa, Yoriko Saito, Shinsuke Takagi, Sadaaki Takata, Hanae Amitani, Mikiko Endo, Naoyuki Uchida, Yukihide Momozawa, Shuichi Taniguchi, Hideo Harigae, Fumihiko Ishikawa

Blood (2021) 138 (Supplement 1): 1236.

https://doi.org/10.1182/blood-2021-147625

Published: 2021

Journal Articles

Genome-Wide Association Study Identifies Variation in ABO As Risk Factor for Platelet Reactivity in Heparin-Induced Thrombocytopenia

Jason B Giles, Jérôme Rollin, PhD, Christian M Shaffer, Heidi E Steiner, Yukihide Momozawa, DVM,PhD, Ian Stanaway, PhD, Taisei Mushiroda, Claire Pouplard, PharmD, PhD, Nancy Heddle, MSc, Michiaki Kubo, MDPhD, Elizabeth Phillips, MD, Theodore E. Warkentin, MD, Yves Gruel, MD PhD, Andreas Greinacher, MD, Dan Roden, MD, Jason Karnes, PhDPharmD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-139651

Published: 2020

Journal Articles

Clinical Impacts of Germline DDX41 Mutations on Myeloid Neoplasms

Hideki Makishima, MD PhD, Yasuhito Nannya, MD PhD, June Takeda, MD, Yukihide Momozawa, DVM,PhD, Ryunosuke Saiki, MD, Tetsuichi Yoshizato, MD PhD, Yoshiko Atsuta, MD PhD, Yuka Iijima-Yamashita, Kenichi Yoshida, MD PhD, Yuichi Shiraishi, PhD, Yasunobu Nagata, MD PhD, Yusuke Shiozawa, MD PhD, Makoto Onizuka, MD PhD, Kenichi Chiba, Hiroko Tanaka, Nobuyuki Kakiuchi, MD, Yotaro Ochi, MD, Hiroo Ueno, MD PhD, Hidehiro Itonaga, MD PhD, Yoshinobu Kanda, MD PhD, Masashi Sanada, MD, Ayana Kon, MD PhD, Yasushi Miyazaki, MD PhD, Keizo Horibe, MD PhD, Maria Creignou, Magnus Tobiasson, MD, Hisashi Tsurumi, MD PhD, Senji Kasahara, MD PhD, Chantana Polprasert, MD, Eva Hellstrom Lindberg, MD PhD, Akifumi Kondo Takaori, MD PhD, Toru Kiguchi, MD PhD, Mario Cazzola, MD, Fumihiko Matsuda, MD PhD, Kazuma Ohyashiki, MD PhD, Jaroslaw P. Maciejewski, MD PhD, Torsten Haferlach, MD, Yoichiro Kamatani, MDPhD, Michiaki Kubo, MDPhD, Satoru Miyano, PhD, Seishi Ogawa, MD PhD

Blood (2020) 136 (Supplement 1): 38–40.

https://doi.org/10.1182/blood-2020-140174

Published: 2020

Journal Articles

PPM1D and DNMT3A Mutations in Myelodysplasia and Clonal Hematopoiesis

Blood (2019) 134 (Supplement_1): 1709.

https://doi.org/10.1182/blood-2019-122032

Published: 2019

Journal Articles

Analysis of Genomic Predispositions to Sporadic Myeloid Neoplasms Mediated By DDX41 in Japan

Blood (2018) 132 (Supplement 1): 4371.

https://doi.org/10.1182/blood-2018-99-117664

Published: 2018

Journal Articles

Genetic Predispositions to Myeloid Neoplasms Caused By Germline DDX41 Mutations

June Takeda, MD, Kenichi Yoshida, MD PhD, Hideki Makishima, MD PhD, Tetsuichi Yoshizato, MD, Yusuke Shiozawa, MD, Yuichi Shiraishi, MD PhD, Yusuke Okuno, MD PhD, Ayana Kon, MD PhD, Yasunobu Nagata, MDPhD, Keisuke Kataoka, MD PhD, Kenichi Chiba, BA, Hiroko Tanaka, BA, Masashi Sanada, MD PhD, Mamiko Sakata-Yanagimoto, MD PhD, Naoshi Obara, MD PhD, Tsuyoshi Nakamaki, MD, Ken Ishiyama, MD PhD, Akira Haigaishi, MDPhD, Shigeru Chiba, MD, PhD, Hiraku Mori, MDPhD, Norio Asou, MD PhD, Hitoshi Kiyoi, MD, Chikara Hirase, MDPhD, Kiyotoshi Imai, MD PhD, Nobuaki Dobashi, MD, Toru Kiguchi, MDPhD, Yasushi Miyazaki, MD PhD, Tomoki Naoe, MD PhD, Satoru Miyano, MD PhD, Kensuke Usuki, MDPhD, Shuichi Miyawaki, MDPhD, Yoichiro Kamatani, MDPhD, Yukihide Momozawa, MD PhD, Michiaki Kubo, MD PhD, Chantana Polprasert, MD, Jaroslaw P. Maciejewski, MD PhD, Seishi Ogawa, MD PhD

Blood (2015) 126 (23): 2843.

https://doi.org/10.1182/blood.V126.23.2843.2843

Published: 2015

NARROW

Combined Targeting Patient-Specific Anti-Apoptotic Molecules and CXCR4-Expressing CAR-T Cells Eliminated High-Inflammation State Leukemia with Poor-Prognostic Mutations

Germ line DDX41 mutations define a unique subtype of myeloid neoplasms

Detailed Analysis of the Impact of Clonal Hematopoiesis on the Risk of Severe COVID-19 Infection

Germline Risks and Clinical Impacts of DDX41 Mutations in Myeloid Malignancies

ABO O blood group as a risk factor for platelet reactivity in heparin-induced thrombocytopenia

Identification of Patient-Specific Anti-Apoptotic Molecules As Therapeutic Targets in Poor Prognosis Acute Lymphoblastic Leukemia (ALL)

Genome-Wide Association Study Identifies Variation in ABO As Risk Factor for Platelet Reactivity in Heparin-Induced Thrombocytopenia

Clinical Impacts of Germline DDX41 Mutations on Myeloid Neoplasms

PPM1D and DNMT3A Mutations in Myelodysplasia and Clonal Hematopoiesis

Analysis of Genomic Predispositions to Sporadic Myeloid Neoplasms Mediated By DDX41 in Japan

Genetic Predispositions to Myeloid Neoplasms Caused By Germline DDX41 Mutations

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only